Aurora Europe
Company Overview
- Name: Aurora Europe
- Industry: Cannabis
- Founded: 2006
- Headquarters: Berlin, Germany
Core Business
Aurora is a pioneer in the medicinal cannabis industry, dedicated to helping people improve their lives. Aurora is a vertically integrated organisation across the cannabis value chain from cultivation to cannabis breeding, genetics research, product development and wholesale distribution. In Europe, we produce and supply high-quality pharmaceutical-grade medical cannabis products to patients in several European markets where cannabis has been legalised for medical purposes.
Global Presence
Aurora Europe (headquartered in Berlin, Germany) is a subsidiary of Aurora Cannabis Inc. (Alberta, Canada), a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.
Innovation & Technology
Aurora Europe supplies physicians, pharmacists and patients with pharmaceutical-grade, European-grown cannabis-based medicines and is introducing new treatment options for patients. What sets us apart:
Experience
Aurora has a long history in developing and producing cannabis-based medicines. Since 2006, the company has developed more than 200 different medical products from cannabis., i.e., dried flowers and extracts.
Quality
Everything we do is geared to ensuring high quality and consistent products for patients. We cultivate our cannabis ourselves and produce according to GACP and EU-GMP standards.
Network
We have a strong international network that enables us to serve patients globally and respond quickly to worldwide demands.
Research
We have a strong heritage in research, both in plant genetics and clinical trials. We have and continue to invest heavily into new research to treat disease areas.
Committed to health
As an organization operating in the healthcare space, we are committed to improving the lives of patients by offering medicines where conventional medicine may not be working. Through many years of working with prescribing physicians, we have seen how cannabis can benefit some patients and our mission is to continue to make a difference to the wellbeing of patients.
Commitment & Sustainability
With more than 9,200 m² production space and an output of approximately 10,000 kg of high-quality medical cannabis per year, our Aurora Nordic facility is well positioned to service European and international markets. Today, the high-tech cultivation facility in Odense, Denmark, produces dried flowers medical cannabis and extracts and will expand its product offerings over the near term. The EU GMP certification of the facility ensures superior levels of quality in both products and processes.
Company Values
A medical company at heart and as a leader in the medical cannabis market, Aurora has a patient-first philosophy. Aurora Europe (headquartered in Berlin, Germany) is a subsidiary of Aurora Cannabis Inc. (Alberta, Canada), a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives. The company supplies high-quality pharmaceutical grade medical cannabis products to patients throughout Europe. In 2017, Aurora entered the German market and is today; one of the largest authorized importers and distributors of medical cannabis in Europe.
Awards & Recognition
Europe’s medical cannabis market is relatively young. Since 2017, 13 European countries have legalised plant-based medical cannabis products: The Czech Republic, Denmark, Germany, Greece, Italy, Ireland, Luxembourg, Malta, The Netherlands, Poland, Portugal, the UK and recently also France within a pilot program. Even before 2017, Aurora had sold products to wholesalers in Germany with special permissions. Since the acquisition of Pedanios GmbH, Aurora has expanded exports across the continent. In many European countries, cannabis flowers and extracts are already eligible for patient reimbursement through the national public healthcare system, with some programs offering 90-100% reimbursement through the national coverage for approved conditions.
Community Engagement
Aurora has been involved in observational and case studies, many of these are conducted in partnership with academic research institutions and world-renowned hospitals. We leverage our cannabis science expertise to cultivate new and unique cultivars, helping us stay ahead of evolving demands.
Please note that specific details about this companies products, innovations, and market presence may evolve over time, so it’s a good idea to visit their official website or check recent news for the most up-to-date information.
